Details of the Drug-Related molecule(s) Interaction Atlas
General Information of Drug (ID: DMDQL24)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
4,5,6,7-Tetrahydro-1H-indazole-3-carboxylic acid; 6076-13-7; 4,5,6,7-Tetrahydro-2H-indazole-3-carboxylic acid; 714255-28-4; CHEMBL338405; LWXNHFZBFJMHGU-UHFFFAOYSA-N; 2H-Indazole-3-carboxylicacid, 4,5,6,7-tetrahydro-; 1H-Indazole-3-carboxylic acid, 4,5,6,7-tetrahydro-; 2H-Indazole-3-carboxylic acid, 4,5,6,7-tetrahydro-; 1H-4,5,6,7-tetrahydroindazole-3-carboxylic acid; MLS000074645; AC1LDJ0A; ChemDiv2_003320; Oprea1_089683; AC1Q748E; SCHEMBL1808017; AC1Q72Q0; CTK2H6469; DTXSID00349466; MolPort-000-767-792; MolPort-000-149-162
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule-Related Drug Atlas
Molecule-Related Drug Atlas
Molecule Type:
DTT Drug Status:
Approved Drug(s) Clinical Trial Drug(s) Discontinued Drug(s) Investigative Drug(s) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug(s) Targeting Nicotinic acid receptor (HCAR2)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Molecular Interaction Atlas | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
References